Capacity Bio
Drug Discovery
Capacity Bio valuation and funding history | Last updated: March 31, 2023 | 2 funding rounds
Current Valuation
N/A
As of March 31, 2023
Total Funding Raised
N/A
Across 2 rounds
Last Round
Early Stage VC
$35.0M
Last Funding
Mar 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| March 31, 2023 | Early Stage VC | $35.0M | N/A | - |
| January 17, 2023 | Seed Round | $19.2M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Capacity Bio is currently valued at N/A as of March 31, 2023.
What is Capacity Bio Worth in 2026?
Capacity Bio is a leading private company in the Drug Discovery sector. Track Capacity Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Capacity Bio Valuation is Determined
Private company valuations like Capacity Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.